Loading clinical trials...
Loading clinical trials...
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Conditions
Interventions
Home Monitoring Guided OAC
Physician-Directed OAC
Locations
80
United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Anaheim, California, United States
Fremont, California, United States
Santa Barbara, California, United States
Torrance, California, United States
Start Date
February 1, 2008
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
December 5, 2017
NCT05093673
NCT06258538
NCT07371455
NCT06870812
NCT07253181
NCT05147792
Lead Sponsor
Biotronik, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions